Page 22

Junio 2017

ARTÍCULO DE INVESTIGACIÓN Predicción de eventos adversos en NAC hospitalizada - F. Saldías Peñafiel et al ticas e información de salud (http://deis.minsal.cl/index. asp) (Acceso en febrero de 2016). 11. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society 702 of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): S27-S72. 12. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. Pneumonia Guidelines Committee of the BTS Standards of Care Committee. The British Thoracic Society Guidelines for the management of community-acquired pneumonia in adults: update 2009. Thorax 2009; 64 (Suppl 3): 1-55. 13. Sociedad Chilena de Enfermedades Respiratorias y Sociedad Chilena de Infectología. Consenso Nacional 2005: Manejo de la neumonía del adulto adquirida en la comunidad. Rev Chil Enf Respir 2005; 21: 69-140. 14. Saldías F, Pavié J. Consenso Chileno de Neumonía Comunitaria. Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad. Rev Chil Infectol 2005; 22 (Supl 1): S39-S45. 15. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000; 283: 749-55. 16. McMahon LF Jr, Wolfe RA, Tedeschi PJ. Variation in hospital admissions among small areas: a comparison of Maine and Michigan. Med Care 1989; 27: 623-31. 17. Fine MJ, Hough LJ, Medsger AR, Li YH, Ricci EM, Singer DE, et al. The hospital admission decision for patients with community-acquired pneumonia: results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1997; 157: 36-44. 18. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify lowrisk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50. 19. Lim WS, Van Der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-82. 20. Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community acquired pneumonia. Clin Infect Dis; 47: 375-84. 21. España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006; 174: 1249-56. 22. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, et al. New emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990; 69: 307-16. 23. Bauer TT, Ewig S, Marre R, Suttorp N, Welte T. The CAPNETZ Study Group. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006; 260: 93-101. 24. Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury G, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 2010; 65: 878-83. 25. Loke YK, Shing Kwok C, Niruban A, Myint PK. Value of severity scales in predicting mortality from community acquired pneumonia: systematic review and meta-analysis. Thorax 2010: 65: 884-90. 26. Singanayagam A, Chalmers JD, Hill AT. Severity assessment in community-acquired pneumonia: a review. QJM 2009; 102: 379-88. 27. Marti C, Garin N, Grosgurin O, Poncet A, Combescure C, Carballo S, et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care 2012; 16: R141. 28. Chalmers JD,  Mandal P,  Singanayagam A,  Akram AR, Choudhury G, Short PM, et al. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med 2011; 37: 1409-20. 29. España PP, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest 2009; 135: 1572-9. 30. Saldías F, Díaz O. Severity scores for predicting clinically relevant outcomes for immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia. Rev Chil Infectol 2011; 28: 303-9. 31. Capelastegui A, España PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006; 27: 151-7. 32. Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006; 61: 419-24. Rev Med Chile 2017; 145: 694-702


Junio 2017
To see the actual publication please follow the link above